IP Library › Granted Patent US 9,540,349

Granted Patent B2

US 9,540,349 · App. 14/800,053 · Granted Jan 10, 2017

Substituted pyrimidine compounds

Inventors: Antonio Nardi (Herzogenrath, DE); Florian Jakob (Aachen, DE); Ingo Konetzki (Aachen, DE); Tobias Craan (Aachen, DE); Christian Hesslinger (Zoznegg, DE)

Assignee: GRUENENTHAL GMBH

C07D403/04 C07D401/14 C07D403/14 C07D405/14 C07D409/14 C07D413/14 C07D417/14 C07D471/04 C07D487/08 C07D491/107

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,540,349
App. No.: 14/800,053
Granted: Jan 10, 2017
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The invention relates to novel substituted pyrimidine compounds of general formula (I) in which the chemical groupings, substituents, variables and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

Claims (165)

1. A compound of formula (I)

wherein

A, B and C independently represent CH or N;

R 1 and R 2 independently represent

hydrogen or (C 1 -C 6 )-alkyl, whereby said (C 1 -C 6 )-alkyl is unsubstituted or substituted with at least one substituent X 1 , or

a group U, which is a 3- to 12-membered mono- or bi-cycloaliphatic ring, which is unsubstituted or substituted with at least one substituent X 2 , whereby said group U may be connected to the nitrogen atom via a C 1-6 -alkylene group, which in turn is unsubstituted or substituted with at least one substituent independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

a group V, which is a 3- to 12-membered mono-or bi-cyclic heterocycloaliphatic ring comprising at least one heteroatom selected from the group consisting of O, S and N as a ring member, and which mono- or bicyclic heterocycloaliphatic ring is unsubstituted or substituted with at least one substituent X 3 , whereby said group V may be connected to the nitrogen atom via a C 1-6 -alkylene group, which in turn may be unsubstituted or substituted with at least one substituent independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

a group W which is phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl is unsubstituted or substituted with at least one substituent X 4 and may be condensed with a 4-, 5-, 6- or 7-membered ring, being carbocyclic or heterocyclic, wherein said condensed ring may be saturated, partially unsaturated or aromatic and may be substituted with at least on substituent X 5 , and whereby group W may be connected to the nitrogen atom via a C 1-6 -alkylene group, which in turn may be unsubstituted or substituted with at least one substituent independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 3- to 12-membered monocyclic or bicyclic non-aromatic or aromatic ring wherein said ring may contain at least one additional heteroatom selected from the group consisting of O,S and N and wherein said ring is unsubstituted or substituted with at least one substituent X 6 ;

R 3 and R 4 ,

independently represent hydrogen, (C 1 -C 6 )-alkyl or (C 3 -C 6 )-cycloalkyl, wherein said (C 1 -C 6 )-alkyl and (C 3 -C 6 )-cycloalkyl are each unsubstituted or substituted with at least one substituent Y 1 , or

together with the carbon atom to which they are attached form a 3- to 6-membered cycloalkyl ring, which is unsubstituted or substituted with at least one substituent Y 2 ;

L represents a bond, O, S, (C 1 -C 6 )-alkylene or (C 2 -C 6 )-alkenylene, whereby the aforementioned alkylenes or alkenylenes are in each case unsubstituted or substituted with at least one substituent selected from the group consisting of F, Cl, CF 3 , ═O,OCF 3 and OH;

G represents a phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl may be substituted with at least one substituent Z;

X 1 , X 2 , X 3 , X 5 and X 6 , at each occurrence are independently from one another selected from the group consisting of OH, ═O,CN, nitro, halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(C 1 -C 6 )-alkyl, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, S(C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 8 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-SO—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-SO—(C 1 -C 6 )-alkyl, NHCONH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CO—N((C 1 -C 6 )-alkyl) 2 , CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

X 4 at each occurrence are independently from one another selected from the group consisting of OH, CN, nitro, halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(C 1 -C 6 )-alkyl, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, S(C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 8 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CO—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-SO—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-SO 2 —(C 1 -C 6 )-alkyl, NHCONH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CO—N((C 1 -C 6 )-alkyl) 2 , CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

Y 1 and Y 2 , at each occurrence are independently from one another selected from the group consisting of OH, ═O CN, nitro, halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(C 1 -C 6 )-alkyl, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, S(C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 8 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CO—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-SO—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-SO 2 —(C 1 -C 6 )-alkyl, NHCONH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CO—N((C 1 -C 6 )-alkyl) 2 , CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

Z at each occurrence is independently selected from the group consisting of halogen, OH, CN, SH, nitro, (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkinyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-thioalkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-thiohaloalkyl, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylen-S—(C 1 -C 6 )-alkyl, (C 3 -C 8 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 3 )-alkylenyl, (C 3 -C 8 )-heterocycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—CO—O—(C 1 -C 6 )-alkyl, NH—C(O)NH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, NH—CO—N((C 1 -C 6 )-alkyl) 2 , NH((C 1 -C 6 )-alkylen)-CO—O—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CONH 2 , NH((C 1 -C 6 )-alkylen)-CO—NH—(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-CO—N((C 1 -C 6 )-alkyl) 2 , NH—S(O) 2 OH, NH—S(O) 2 (C 1 -C 6 )-alkyl, NH—S(O) 2 O(C 1 -C 6 )-alkyl, NH—S(O) 2 NH 2 , NH—S(O) 2 NH(C 1 -C 6 )-alkyl, NH—S(O) 2 N((C 1 -C 6 )-alkyl) 2 , NH((C 1 -C 6 )-alkylen)-S(O) 2 OH, NH((C 1 -C 6 )-alkylen)-S(O) 2 (C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-S(O) 2 O(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-S(O) 2 NH 2 , NH((C 1 -C 6 )-alkylen)-S(O) 2 NH(C 1 -C 6 )-alkyl, CO 2 H, CO(C 1 -C 6 )-alkyl, CO—O(C 1 -C 6 )-alkyl, O—CO(C 1 -C 6 )-alkyl, O—CO—O(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )-alkyl, CO—N((C 1 -C 6 )-alkyl) 2 ,O—CO—NH(C 1 -C 6 )-alkyl, O—CO—N((C 1 -C 6 )-alkyl) 2 , O—S(O) 2 —(C 1 -C 6 )-alkyl, O—S(O) 2 OH, O—S(O) 2 —(C 1 -C 6 )-alkoxy, O—S(O) 2 NH 2 ,O—S(O) 2 —NH(C 1 -C 6 )-alkyl, O—S(O) 2 —N((C 1 -C 6 )-alkyl) 2 , S(O)(C 1 -C 6 )-alkyl, S(O) 2 (C 1 -C 6 )-alkyl, S(O) 2 OH, S(O) 2 O(C 1 -C 6 )-alkyl, S(O) 2 NH 2 , S(O) 2 NH(C 1 -C 6 )-alkyl, and S(O) 2 N((C 1 -C 6 )-alkyl) 2 ;

optionally in the form of a single stereoisomer or a mixture of stereoisomers, in the form of the free compound and/or a physiologically acceptable salt and/or a physiologically acceptable solvate thereof.

2. The compound of claim 1 , wherein

A, B and C independently represent CH or N;

R 1 and R 2 independently represent

hydrogen or (C 1 -C 6 )-alkyl, whereby said (C 1 -C 6 )-alkyl is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 1 , or

a group U, which is a 3- to 12-membered mono- or bi-cycloaliphatic ring, which is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 2 , whereby said group U may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn is unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

a group W which is phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl is unsubstituted or substituted with 1, 2, 3, 4, or 5 substituents X 4 , and wherein said phenyl or said heteroaryl may be condensed with a 4-, 5-, 6- or 7-membered ring, being carbocyclic or heterocyclic, wherein said condensed ring may be saturated, partially unsaturated or aromatic and is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 5 ; and wherein said group W may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn may be unsubstituted or substituted with at least one substituent independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 3- to 12-membered monocyclic or bicyclic non-aromatic or aromatic ring wherein said ring may contain 1, 2 or 3 additional heteroatoms selected from the group consisting of O, S and N and wherein said ring is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 6 ;

R 3 and R 4 ,

together with the carbon atom to which they are attached form a 3- to 6-membered cycloalkyl ring, which is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents Y 2 ;

L represents a bond, O,S, (C 1 -C 6 )-alkylene or (C 2 -C 6 )-alkenylene, whereby the aforementioned alkylenes or alkenylenes are in each case unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH;

G represents a phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents Z;

X 1 , X 2 , X 3 , X 5 and X 6 , at each occurrence are independently from one another selected from the group consisting of OH, ═O, CN, F, Cl, Br, CHF 2 , CH 2 F, CF 3 , OCF 3 , SCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(C 1 -C 6 )-alkyl, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, CO 2 H, CO—(C 1 -C 6 )-alkyl, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

X 4 at each occurrence is independently selected from the group consisting of OH, CN, F, Cl, Br, CHF 2 , CH 2 F, CF 3 , OCF 3 , SCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(C 1 -C 6 )-alkyl, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, NHCONH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-CO—N((C 1 -C 6 )-alkyl) 2 , CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

Y 1 and Y 2 , at each occurrence, are independently from one another selected from the group consisting of OH, ═O, CN, F, Cl, Br, CHF 2 , CH 2 F, CF 3 , OCF 3 , SCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(C 1 -C 6 )-alkyl, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 -(C 1 -C 6 )-alkyl, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

Z at each occurrence is independently selected from the group consisting F, Cl, Br, CHF 2 , CH 2 F, CF 3 , OCF 3 , SCF 3 , OH, CN, SH, nitro, (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkinyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-thioalkyl, (C 1 -C 6 )-alkylen-S—(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, hydroxyl-(C 3 -C 6 )-cycloalkyl, (C 3 -C 8 )-heterocycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—CO—O—(C 1 -C 6 )-alkyl, NH—S(O) 2 OH, NH—S(O) 2 (C 1 -C 6 )-alkyl, NH—S(O) 2 O(C 1 -C 6 )-alkyl, NH—S(O) 2 NH 2 , NH—S(O) 2 NH(C 1 -C 6 )-alkyl, NH—S(O) 2 N((C 1 -C 6 )-alkyl) 2 , NH((C 1 -C 6 )-alkylen)-S(O) 2 OH, NH((C 1 -C 6 )-alkylen)-S(O) 2 (C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-S(O) 2 O(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-S(O) 2 NH 2 , NH((C 1 -C 6 )-alkylen)-S(O) 2 NH(C 1 -C 6 )-alkyl, CO 2 H, CO(C 1 -C 6 )-alkyl, CO—O(C 1 -C 6 )-alkyl, O—CO(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )-alkyl, CO—N((C 1 -C 6 )-alkyl) 2 , O—CO—NH(C 1 -C 6 )-alkyl, O—CO—N((C 1 -C 6 )-alkyl) 2 , O—S(O) 2 —(C 1 -C 6 )-alkyl, O—S(O) 2 OH, O—S(O) 2 —(C 1 -C 6 )-alkoxy, O—S(O) 2 NH 2 , O—S(O) 2 —NH(C 1 -C 6 )-alkyl, O—S(O) 2 —N((C 1 -C 6 )-alkyl) 2 , S(O)(C 1 -C 6 )-alkyl, S(O) 2 (C 1 -C 6 )-alkyl, CH 2 S(O)(C 1 -C 6 )-alkyl, CH 2 S(O) 2 (C 1 -C 6 )-alkyl, S(O) 2 OH, S(O) 2 O(C 1 -C 6 )-alkyl, S(O) 2 NH 2 , S(O) 2 NH(C 1 -C 6 )-alkyl, and S(O) 2 N((C 1 -C 6 )-alkyl) 2 ;

3. The compound of claim 1 , wherein

A, B and C independently represent CH or N;

R 1 and R 2 independently represent

hydrogen or (C 1 -C 6 )-alkyl, whereby said (C 1 -C 6 )-alkyl is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 1 ; whereby at each occurrence X 1 is independently selected from the group consisting of F, Cl, Br, CN, (C 1 -C 6 )-alkoxy, OH, CONH 2 , CONH(C 1 -C 6 )-alkyl, CON((C 1 -C 6 )-alkyl) 2 , NH 2 , NH(C 1 -C 6 )-alkyl and N((C 1 -C 6 )-alkyl) 2 , or

a group U, which is a 3- to 12-membered mono- or bi-cycloaliphatic ring, which is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 2 , whereby at each occurrence X 2 is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ; and whereby said group U may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn is unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

a group V, which is a 3- to 12-membered mono-or bi-cyclic heterocycloaliphatic ring comprising at 1, 2 or 3 heteroatoms selected from the group consisting of O, S and N as ring members, and which mono- or bicyclic heterocycloaliphatic ring is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 3 , whereby at each occurrence X 3 is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ; and whereby said group V may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn is unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

a group W which is phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl is unsubstituted or substituted with 1, 2, 3, 4, or 5 substituents X 4 , whereby at each occurrence X 4 is independently selected from the group consisting of OH, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-CO—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-SO—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-SO 2 —(C 1 -C 6 )-alkyl, NHCONH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-CO—N((C 1 -C 6 )-alkyl) 2 , CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ; and wherein said phenyl or said heteroaryl may be condensed with a 4-, 5-, 6- or 7-membered ring, being carbocyclic or heterocyclic, wherein said condensed ring may be saturated, partially unsaturated or aromatic and is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents X 5 , whereby at each occurrence X 5 is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ; and wherein said group W may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn may be unsubstituted or substituted with at least one substituent independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH, or

R 1 and R 2 together with the nitrogen atom to which they are attached form a 3- to 12-membered monocyclic or bicyclic non-aromatic ring wherein said ring may contain at least one additional heteroatom selected from the group consisting of O, S and N and wherein said ring is unsubstituted or substituted with at least one substituent X 6 ; whereby at each occurrence X 6 is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-alkoxy, (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—(C 1 -C 6 )-alkyl, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

R 3 and R 4 ,

independently of one another, each represent hydrogen, (C 1 -C 6 )-alkyl or (C 3 -C 6 )-cycloalkyl, wherein said (C 1 -C 6 )-alkyl and (C 3 -C 6 )-cycloalkyl are each unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents Y 1 , wherein at each occurrence Y 1 is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 , or

together with the carbon atom to which they are attached form a 3- to 6-membered cycloalkyl ring, which is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents Y 2 , wherein at each occurrence Y 2 is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ;

L represents a bond, O, S, or (C 1 -C 6 )-alkylene, whereby the aforementioned alkylenes are in each case unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH;

G represents a phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl is unsubstituted or substituted with 1, 2, 3, 4 or 5 substituents Z;

whereby at each occurrence Z is independently selected from the group consisting of F, Cl, Br, CHF 2 , CH 2 F, CF 3 , OCF 3 , SCF 3 , OH, CN, SH, nitro, (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkinyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-thioalkyl, (C 1 -C 6 )-alkylen-S—(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, hydroxyl-(C 3 -C 6 )-cycloalkyl, (C 3 -C 8 )-heterocycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—CO—O—(C 1 -C 6 )-alkyl, NH—S(O) 2 OH, NH—S(O) 2 (C 1 -C 6 )-alkyl, NH—S(O) 2 O(C 1 -C 6 )-alkyl, NH—S(O) 2 NH 2 , NH—S(O) 2 NH(C 1 -C 6 )-alkyl, NH—S(O) 2 N((C 1 -C 6 )-alkyl) 2 , NH((C 1 -C 6 )-alkylen)-S(O) 2 OH, NH((C 1 -C 6 )-alkylen)-S(O) 2 (C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-S(O) 2 O(C 1 -C 6 )-alkyl, NH((C 1 -C 6 )-alkylen)-S(O) 2 NH 2 , NH((C 1 -C 6 )-alkylen)-S(O) 2 NH(C 1 -C 6 )-alkyl, CO 2 H, CO(C 1 -C 6 )-alkyl, CO—O(C 1 -C 6 )-alkyl, O—CO(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )-alkyl, CO—N((C 1 -C 6 )-alkyl) 2 , O—CO—NH(C 1 -C 6 )-alkyl, O—CO—N((C 1 -C 6 )-alkyl) 2 , O—S(O) 2 —(C 1 -C 6 )-alkyl, O—S(O) 2 OH, O—S(O) 2 —(C 1 -C 6 )-alkoxy, O—S(O) 2 NH 2 , O—S(O) 2 —NH(C 1 -C 6 )-alkyl, O—S(O) 2 —N((C 1 -C 6 )-alkyl) 2 , S(O)(C 1 -C 6 )-alkyl, S(O) 2 (C 1 -C 6 )-alkyl, CH 2 S(O)(C 1 -C 6 )-alkyl, CH 2 S(O) 2 (C 1 -C 6 )-alkyl, S(O) 2 OH, S(O) 2 O(C 1 -C 6 )-alkyl, S(O) 2 NH 2 , S(O) 2 NH(C 1 -C 6 )-alkyl, and S(O) 2 N((C 1 -C 6 )-alkyl) 2 ;

4. The compound of claim 1 , wherein each of A, B and C represents CH.

5. The compound of claim 1 , wherein

R 1 and R 2 independently represent

Hydrogen or an alkyl selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, s-butyl and t-butyl, whereby said alkyl is unsubstituted or substituted with 1, 2 or 3 substituents independently from one another selected from the group consisting of methoxy, ethoxy, OH, F, Cl, CN, CONH 2 , CONH(CH 3 ), CON(CH 3 ) 2 , NH 2 , NH(CH 3 ) and N(CH 3 ) 2 ,

represent one of the following groups U1 to U11:

whereby at each occurrence n is 0, 1, 2, 3, 4 or 5, and

whereby at each occurrence X 2 is independently selected from the group consisting of OH, ═O,CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ,

and

whereby said group U may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn is unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH,

represent one of the following groups V1 to V35:

whereby at each occurrence m is 0, 1, 2, 3, 4 or 5, and

X 3 at each occurrence is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ; and wherein said group V may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn is unsubstituted or substituted with 1, 2 or 3 substituents independently selected from the group consisting of F, Cl, CF 3 , ═O,OCF 3 and OH,

represent one of the following groups W1 to W47:

wherein at each occurrence o represents 0, 1, 2, 3, 4 or 5, and

X 4 at each occurrence is independently selected from the group consisting of OH, CN, F, Cl, Br, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-alkoxy, S(O)—(C 1 -C 6 )-alkyl, S(O) 2 —(C 1 -C 6 )-alkyl, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, NH—SO—(C 1 -C 6 )-alkyl, NH—S(O) 2 —(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-CO—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-SO—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-SO—(C 1 -C 6 )-alkyl, NHCONH 2 , NH—CO—NH—(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl)-CO—N((C 1 -C 6 )-alkyl) 2 , CO 2 H, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 )alkyl and CO—N((C 1 -C 6 )-alkyl) 2 ; and wherein said group W may be connected to the nitrogen atom via a C 1-3 -alkylene group, which in turn may be unsubstituted or substituted with at least one substituent independently selected from the group consisting of F, Cl, CF 3 , ═O, OCF 3 and OH.

6. The compound of claim 1 , wherein

R 1 and R 2 together with the nitrogen atom to which they are attached form a ring selected from the following groups Q1 to Q34:

in which the site marked with an asterisk (*) indicates the binding site, which is bonded to the carbonyl group;

R 5 is H, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-cyanoalkyl, (C 3 -C 6 )-cycloalkyl, CO—(C 1 -C 6 )-alkyl or SO 2 —(C 1 -C 6 )-alkyl;

at each occurrence p is 0, 1, 2, 3, 4 or 5; and

X 6 at each occurrence is independently selected from the group consisting of OH, ═O, CN, F, Cl, Br, CF 3 , CHF 2 , CH 2 F, OCF 3 , (C 1 -C 6 )-alkyl, (C 1 -C 6 )-hydroxyalkyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-alkoxy, (C 3 -C 6 )-cycloalkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , NH—CO—(C 1 -C 6 )-alkyl, CO 2 H, CO—(C 1 -C 6 )-alkyl, CO—O—(C 1 -C 6 )-alkyl, CONH 2 , CO—NH(C 1 -C 6 ) alkyl and CO—N((C 1 -C 6 )-alkyl) 2 .

7. The compound of claim 1 , wherein the substructure M

represents one of the following substructures M1 to M60:

wherein R 1 is H, CH 3 , CH 2 CH 3 , CH(CH 3 ) 2 , CH 2 CH 2 OH, CH 2 CH 2 OCH 3 or cyclopropyl.

8. The compound of claim 1 , wherein

R 3 and R 4 each represent CH 3 , or

R 3 and R 4 together with the carbon atom to which they are attached form a cyclopropyl or cyclobutyl.

9. The compound of claim 1 , wherein L represents a bond.

10. The compound of claim 1 , wherein G is one of the following groups G1 to G44:

in which the site marked with an asterisk (*) indicates the binding site, which is bonded to the pyrimidine ring;

R 12 is selected H, CH 3 or CH 2 CH 3 ;

k at each occurrence 0, 1, 2, 3, 4 or 5; and

Z at each occurrence is independently selected from the group consisting of F, Cl, CN, CF 3 , CHF 2 , CH 2 F, OCF 3 , OH, OCH 3 , OC 2 H 5 , OCOCH 3 , CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH 2 CH 2 CH 2 CH 3 , CH(CH 3 )CH 2 CH 3 , CH 2 CH(CH 3 ) 2 , C(CH 3 ) 3 , CONH 2 , CONHCH 3 , CON(CH 3 ) 2 , NH 2 , NH(CH 3 ), NH(CH 2 CH 3 ), NH(CH 2 -c-propyl), N(CH 3 ) 2 , NHCOCH 3 , CH 2 OH, CH 2 CH 2 OH, C(CH 3 ) 2 OH, CH(CH 3 )OH, CH 2 CN, SOCH 3 , SO 2 CH 3 , SOCH 2 CH 3 , SO 2 CH 2 CH 3 , SO 2 NH 2 , CH 2 SOCH 3 , CH 2 SO 2 CH 3 , N-pyrrolidinyl, cyclopropyl, 1-hydroxy-cycloprop-1-yl, cyclobutyl, cyclopentyl and cyclohexyl.

11. The compound of claim 10 having formula I′

wherein R 1 and R 2 together with the nitrogen atom to which they are attached form one of the following heterocycles Q19, Q23, Q25 or Q26:

in which the site marked with an asterisk (*) indicates the binding site, which is bonded to the carbonyl group;

R 5 is H, CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , cyclopropyl, C(O)CH 3 , C(O)CH 2 CH 3 , C(O)CH 2 CH 2 CH 3 , C(O)CH(CH 3 ) 2 , C(O)-cyclopropyl, CH 2 CH 2 CN, CH 2 CH 2 OH or CH 2 CH 2 OCH 3 ;

at each occurrence p is 0, 1, 2 or 3; and

X 6 represents H, C(O)CH 3 , C(O)CH 2 CH 3 , CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH 2 CH 2 CH 2 CH 3 , CH 2 CH(CH 3 ) 2 , CH(CH 3 )(CH 2 CH 3 ), CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl, OH, OCH 3 , OCH 2 CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 ;

in which R 1 stands for CH 3 or cyclopropyl and

R 2 stands for CH 2 CH 2 OH, CH 2 CH 2 CH 2 OH, (R)—CH 2 CH(OH)CH 2 CH 2 OH, (S)—CH 2 CH(OH)CH 2 CH 2 OH, (R)-2-CH 2 CH(CH 3 )OH, (S)—CH 2 CH(CH 3 )OH, (R)—CH(CH 3 )CH 2 OH, (S)—CH(CH 3 )CH 2 OH.

12. A pharmaceutical composition comprising the compound of claim 1 .

13. The compound of claim 7 having formula I-h

wherein the substructure M is selected from the group consisting of M1 to M12, M25 and M27 to M30,

R 1 is H or CH 3 or cyclopropyl,

Z is selected from the group consisting of F, Cl, CN, CF 3 , CHF2, CH2F, OCF 3 , OH, OCH 3 , OC 2 H 5 , CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH 2 CH 2 CH 2 CH 3 , CH(CH 3 )CH 2 CH 3 , CH 2 CH(CH 3 ) 2 , C(CH 3 ) 3 , CONH 2 , CONHCH 3 , CON(CH 3 ) 2 , NH 2 , NH(CH 3 ), N(CH 3 ) 2 , NHCOCH 3 , CH 2 OH, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl, and

k is 0, 1, or 2.

14. The compound of claim 1 having formula I-i,

wherein Z is selected from the group consisting of F, Cl, CN, CF 3 , CHF 2 , CH 2 F, OCF 3 , OH, OCH 3 , OC 2 H 5 , OCOCH 3 , CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH 2 CH 2 CH 2 CH 3 , CH(CH 3 )CH 2 CH 3 , CH 2 CH(CH 3 ) 2 , C(CH 3 ) 3 , CONH 2 , CONHCH 3 , CON(CH 3 ) 2 , NH 2 , NH(CH 3 ), NH(CH 2 CH 3 ), NH(CH 2- c-propyl), N(CH 3 ) 2 , NHCOCH 3 , CH 2 OH, CH 2 CH 2 OH, C(CH 3 ) 2 OH, CH(CH 3 )OH, CH 2 CN, SOCH 3 , SO 2 CH 3 , SOCH 2 CH 3 , SO 2 CH 2 CH 3 , SO 2 NH 2 , CH 2 SOCH 3 , CH 2 SO 2 CH 3 , N-pyrrolidinyl, cyclopropyl, 1-hydroxy-cycloprop-1-yl, cyclobutyl, cyclopentyl and cyclohexyl, and

k is 0, 1, or 2.

15. The compound of claim 1 having formula I-j,

k is 0, 1, or 2,

R 5 is H, CH 3 , CH2CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , cyclopropyl, C(O)CH 3 , C(O)CH 2 CH 3 , C(O)CH 2 CH 2 CH 3 , C(O)CH(CH 3 ) 2 , C(O)-cyclopropyl, CH 2 CH 2 CN, CH 2 CH 2 OH or CH 2 CH 2 OCH 3 ;

p is 0, 1, 2 or 3, and

each X 6 represents CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl cyclohexyl, OH, OCH 3 , OCH2CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 .

16. The compound of claim 1 haying formula I-k,

k is 0, 1, or 2,

R 5 is H, CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , cyclopropyl, C(O)CH 3 , C(O)CH 2 CH 3 , C(O)CH 2 CH 2 CH 3 , C(O)CH(CH 3 ) 2 , C(O)-cyclopropyl, CH 2 CH 2 CN, CH 2 CH 2 OH or CH 2 CH 2 OCH 3 ,

p is 0, 1, 2 or 3, and

each X 6 represents CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl cyclohexyl, OH, OCH 3 , OCH 2 CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 .

17. The compound of claim 1 haying formula I-l,

k is 0, 1, or 2,

p is 0, 1, 2 or 3, and

each X 6 represents CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl cyclohexyl, OH, OCH 3 , OCH 2 CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH2OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 .

18. The compound of claim 1 haying formula I-m,

k is 0, 1, or 2, and

R 2 represents CH 2 CH 2 OH, CH 2 CH 2 CH 2 OH, (R)-2-CH 2 CH(CH 3 )OH, (S)-CH 2 CH(CH 3 )OH, (R)-CH(CH 3 )CH 2 OH (S)-CH(CH 3 )CH 2 OH, (R)-CH 2 CH(OH)CH 2 CH 2 OH or (S)-CH 2 CH(OH)CH 2 CH 2 OH.

19. The compound of claim 1 haying formula I-n,

k is 0, 1, or 2, and

R 2 represents CH 2 CH 2 OH, CH 2 CH 2 CH 2 OH, (R)-2-CH 2 CH(CH 3 )OH, (S)-CH 2 CH(CH 3 )OH, (R)-CH(CH 3 )CH 2 OH (S)-CH(CH 3 )CH 2 OH, (R)-CH 2 CH(OH)CH 2 CH 2 OH or (S)-CH 2 CH(OH)CH 2 CH 2 OH.

20. The compound of claim 7 having formula I-o,

wherein the substructure M is selected from the group consisting of M1 to M12, M25 and M27 to M30,

R 1 is H or CH 3 or cyclopropyl,

Z is selected from the group consisting of F, Cl, CN, CF 3 , CHF 2 , CH 2 F, OCF 3 , OH, OCH 3 , OC 2 H 5 , OCOCH 3 , CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH 2 CH 2 CH 2 CH 3 , CH(CH 3 )CH 2 CH 3 , CH 2 CH(CH 3 ) 2 , C(CH 3 ) 3 , CONH 2 , CONHCH 3 , CON(CH 3 ) 2 , NH 2 , NH(CH 3 ), NH(CH 2 CH 3 ), NH(CH 2- c-propyl), N(CH 3 ) 2 , NHCOCH 3 , CH 2 OH, CH 2 CH 2 OH, C(CH 3 ) 2 OH, CH(CH 3 )OH, CH 2 CN, SOCH 3 , SO 2 CH 3 , SOCH 2 CH 3 , SO 2 CH 2 CH 3 , SO 2 NH 2 , CH 2 SOCH 3 , CH 2 SO 2 CH 3 , N-pyrrolidinyl, cyclopropyl, 1-hydroxy-cycloprop-1-yl, cyclobutyl, cyclopentyl and

k is 0, 1, or 2.

21. The compound of claim 1 haying formula I-p,

k is 0, 1, or 2.

22. The compound of claim 1 haying formula I-q,

k is 0, 1, or 2, R 5 is H, CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , cyclopropyl, C(O)CH 3 , C(O)CH 2 CH 3 , C(O)CH 2 CH 2 CH 3 , C(O)CH(CH 3 ) 2 , C(O)-cyclopropyl, CH 2 CH 2 CN, CH 2 CH 2 OH or CH 2 CH 2 OCH 3 ,

p is 0, 1, 2 or 3, and

each X 6 represents CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl cyclohexyl, OH, OCH 3 , OCH 2 CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 .

23. The compound of claim 1 having formula I-r,

k is 0, 1, or 2,

p is 0, 1, 2 or 3, and

each X 6 represents CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl cyclohexyl, OH, OCH 3 , OCH 2 CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 .

24. The compound of claim 1 having formula I-s,

k is 0, 1, or 2,

p is 0, 1, 2 or 3, and

each X 6 represents CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH(CH 3 ) 2 , CH(CH 3 ) 3 , cyclopropyl, cyclobutyl, cyclopentyl cyclohexyl, OH, OCH 3 , OCH 2 CH 3 , OCH(CH 3 ) 2 , NH 2 , N(H)CH 3 , N(CH 3 ) 2 , N(H)C(O)CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 OCH 3 or CH 2 CH 2 OCH 3 .

25. The compound of claim 1 having formula I-t,

k is 0, 1, or 2, and

R 2 represents CH 2 CH 2 OH, CH 2 CH 2 CH 2 OH, (R)-2-CH 2 CH(CH 3 )OH, (S)-CH 2 CH(CH 3 )OH, (R)-CH(CH 3 )CH 2 OH (S)-CH(CH 3 )CH 2 OH, (R)-CH 2 CH(OH)CH 2 CH 2 OH or (S)-CH 2 CH(OH)CH 2 CH 2 OH.

26. The compound of claim 1 haying formula I-u,

k is 0, 1, or 2, and

R 2 represents CH 2 CH 2 OH, CH 2 CH 2 CH 2 OH, (R)-2-CH 2 CH(CH 3 )OH, (S)-CH 2 CH(CH 3 )OH, (R)-CH(CH 3 )CH 2 OH (S)-CH(CH 3 )CH 2 OH, (R)-CH 2 CH(OH)CH 2 CH 2 OH or (S)-CH 2 CH(OH)CH 2 CH 2 OH.

Assignments (1)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2015

From: NARDI, ANTONIO, DR; JAKOB, FLORIAN, DR; KONETZKI, INGO, DR; CRAAN, TOBIAS, DR; HESSLINGER, CHRISTIAN, DR; DOODEMAN, ROBIN, DR

To: GRUENENTHAL GMBH

Reel/Frame 036592/0331 →

Priority Claims (1)

EP 14002452 · Jul 16, 2014 · regional

Continuity (1)

Related Publication 20160016937A1 · Jan 21, 2016